Inovio Pharmaceuticals Inc (INO)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.43+5.15%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · INO
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | 0.1 | 0.2 | 0.8 | 10.3 | 1.8 | 7.4 | 4.1 | 30.5 | 42.2 | 35.4 | 40.6 | 10.5 | 13.5 | 4.1 | 9.8 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 42.2 | 35.4 | 40.6 | 10.5 | 13.5 | 4.1 | 9.8 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 48.5 | 54.2 | 75.6 | 86.7 | 187.7 | 249.2 | 94.2 | 88.0 | 95.3 | 98.6 | 88.7 | 57.8 | 34.1 | 21.4 | 18.0 | 20.0 |
| Operating Income | (79.3) | (86.8) | (112.4) | (143.9) | (267.6) | (301.2) | (124.1) | (111.1) | (94.1) | (83.6) | (76.2) | (34.3) | (39.5) | (19.5) | (23.5) | (21.6) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | 0.2 | 1.2 | 1.3 | 1.9 | 8.7 | 7.9 | — | — | — | — | — | — | — | — |
| Interest & Investment Income | 1.8 | 2.4 | 4.8 | 8.1 | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Interest Expenses | — | — | — | (6.9) | — | — | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | (84.9) | (107.3) | (135.1) | (277.7) | (303.2) | (162.9) | (120.8) | (94.8) | (88.2) | (73.7) | (31.2) | — | — | — | — |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | (0.3) | 2.2 | 0.0 | 0.0 | (2.1) | 0.0 | 0.0 | 0.0 | — |
| Net Income | ||||||||||||||||
| Minority Interest | — | — | — | — | 0.0 | 0.0 | (1.1) | (1.2) | — | 0.0 | 0.0 | 0.1 | (0.0) | (0.1) | (0.0) | (0.1) |
| Net Income | (67.5) | (84.9) | (107.3) | (135.0) | (279.8) | (303.7) | (166.4) | (119.4) | (97.0) | (88.2) | (73.7) | (29.2) | (36.1) | (66.0) | (19.7) | (15.3) |
| Per Share | ||||||||||||||||
| Basic EPS | (0.83) | (1.81) | (3.95) | (6.09) | (14.07) | (17.45) | (1.07) | (1.21) | (1.05) | (1.08) | (1.01) | (0.43) | (0.61) | — | — | — |
| Diluted EPS | (0.83) | (1.81) | (3.95) | (6.09) | (14.07) | (17.45) | (1.07) | (1.21) | (1.05) | (1.09) | (1.01) | (0.44) | (0.64) | — | — | — |
| Basic Weighted Avg Shares | 81.6 | 46.9 | 27.2 | 22.2 | 19.9 | 17.4 | 155.1 | 98.7 | 92.5 | 81.8 | 73.2 | 68.2 | 59.1 | — | — | — |
| Diluted Weighted Avg Shares | 81.6 | 46.9 | 27.2 | 22.2 | 19.9 | 17.4 | 155.1 | 98.7 | 92.5 | 81.9 | 73.2 | 68.4 | 59.4 | — | — | — |
| Supplemental | ||||||||||||||||
| EBIT | (79.3) | (86.8) | (112.4) | (143.9) | (267.6) | (301.2) | (124.1) | (111.1) | (94.1) | (83.6) | (76.2) | (34.3) | (39.5) | (19.5) | (23.5) | (21.6) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.2% | -2.3% | 0.0% | 0.0% | 6.7% | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.